Effect of CYP2C19, UGT1A8, and UGT2B7 on valproic acid clearance in children with epilepsy: a population pharmacokinetic model

被引：0
|
作者：
Shenghui Mei
Weixing Feng
Leting Zhu
Xingang Li
Yazhen Yu
Weili Yang
Baoqin Gao
Xiaojuan Wu
Fang Fang
Zhigang Zhao
机构：
[1] Capital Medical University,Department of Pharmacy, Beijing Tiantan Hospital
[2] Capital Medical University,Department of Clinical Pharmacology, College of Pharmaceutical Sciences
[3] Capital Medical University,Department of Neurology, Beijing Children’s Hospital
[4] Capital Medical University,Department of Pediatrics, Beijing Tiantan Hospital
来源：
European Journal of Clinical Pharmacology | 2018年 / 74卷
关键词：
Valproic acid; Uridine diphosphate glucuronosyltransferase; Cytochrome P450 family 2 subfamily C member 19; Clearance; Children; Population pharmacokinetic model; Nonlinear mixed-effects modeling;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1029 / 1036
页数：7
相关论文
共 50 条
  • [1] Effect of CYP2C19, UGT1A8, and UGT2B7 on valproic acid clearance in children with epilepsy: a population pharmacokinetic model
    Mei, Shenghui
    Feng, Weixing
    Zhu, Leting
    Li, Xingang
    Yu, Yazhen
    Yang, Weili
    Gao, Baoqin
    Wu, Xiaojuan
    Fang, Fang
    Zhao, Zhigang
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (08) : 1029 - 1036
  • [2] Effects of UGT1A6, UGT2B7, and CYP2C9 Genotypes on Plasma Concentrations of Valproic Acid in Chinese Children with Epilepsy
    Guo, Yingjie
    Hu, Cheng
    He, Xiaojing
    Qiu, Feng
    Zhao, Limei
    DRUG METABOLISM AND PHARMACOKINETICS, 2012, 27 (05) : 536 - 542
  • [3] In vitro glucuronidation of mycophenolic acid by human UGTs and the impact of known polymorphisms of UGT1A8, UGT1A9, and UGT2B7
    Bernard, O
    Guillemette, C
    DRUG METABOLISM REVIEWS, 2003, 35 : 53 - 53
  • [4] Influence of UGT1A8 and UGT2B7 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients
    Hideaki Kagaya
    Kazuyuki Inoue
    Masatomo Miura
    Shigeru Satoh
    Mitsuru Saito
    Hitoshi Tada
    Tomonori Habuchi
    Toshio Suzuki
    European Journal of Clinical Pharmacology, 2007, 63 : 279 - 288
  • [5] The impact of UGT1A8, UGT1A9, and UGT2B7 genetic polymorphisms on the pharmacokinetic profile of mycophenolic acid after a single oral dose in healthy volunteers
    Levesque, E.
    Delage, R.
    Benoit-Biancamano, M-O
    Caron, P.
    Bernard, O.
    Couture, F.
    Guillemette, C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (03) : 392 - 400
  • [6] Influence of UGT1A8 and UGT2B7 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients
    Kagaya, Hideaki
    Inoue, Kazuyuki
    Miura, Masatomo
    Satoh, Shigeru
    Saito, Mitsuru
    Tada, Hitoshi
    Habuchi, Tomonori
    Suzuki, Toshio
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (03) : 279 - 288
  • [7] Influence of valproic acid concentration and polymorphism of UGT1A4*3, UGT2B7 -161C > T and UGT2B7*2 on serum concentration of lamotrigine in Chinese epileptic children
    Limin Liu
    Limei Zhao
    Qiuning Wang
    Feng Qiu
    Xiujun Wu
    Yanan Ma
    European Journal of Clinical Pharmacology, 2015, 71 : 1341 - 1347
  • [8] Association of UGT2B7 and CaMK4 with response of valproic acid in Chinese children with epilepsy
    Wang, Yan
    Li, Zhiping
    THERAPIE, 2020, 75 (03): : 261 - 270
  • [9] The influence of UGT2B7 genotype on valproic acid pharmacokinetics in Chinese epilepsy patients
    Sun Yin-xiang
    Zhuo Wen-yan
    Lin Hong
    Peng Zheng-ke
    Wang Hua-ming
    Huang Hao-wu
    Luo Yu-hong
    Tang Fa-qing
    EPILEPSY RESEARCH, 2015, 114 : 78 - 80
  • [10] Influence of nonsynonymous polymorphisms of UGT1A8 and UGT2B7 metabolizing enzymes on the formation of phenolic and acyl glucuronides of mycophenolic acid
    Bernard, Olivier
    Tojcic, Jelena
    Journault, Kim
    Perusse, Louis
    Guillemette, Chantal
    DRUG METABOLISM AND DISPOSITION, 2006, 34 (09) : 1539 - 1545
12345